Juan-Cheng Yang Selected Research

Juan-Cheng Yang Research Topics

Disease

14	Neoplasms (Cancer) 02/2022 - 08/2011
3	Breast Neoplasms (Breast Cancer) 03/2021 - 08/2011
2	Ovarian Neoplasms (Ovarian Cancer) 02/2022 - 01/2022
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 11/2019
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2016
2	Lung Neoplasms (Lung Cancer) 01/2020 - 11/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 02/2019
1	COVID-19 01/2022
1	Infections 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Wounds and Injuries (Trauma) 03/2021
1	Surgical Wound 03/2021
1	Opioid-Related Disorders (Opiate Addiction) 01/2021
1	Ovarian Epithelial Carcinoma 02/2020
1	Adenocarcinoma of Lung 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Melanoma (Melanoma, Malignant) 10/2018
1	Prostatic Neoplasms (Prostate Cancer) 06/2018
1	Body Weight (Weight, Body) 06/2018
1	Disease Progression 01/2018
1	Leukemia 10/2016
1	Inflammation (Inflammations) 08/2014

Drug/Important Bio-Agent (IBA)

6	Cisplatin (Platino)FDA LinkGeneric 02/2022 - 01/2016
2	Aurora Kinase AIBA 02/2022 - 01/2022
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2018
2	Aromatase (CYP19)IBA 01/2022 - 11/2019
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2022 - 11/2019
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 03/2021 - 01/2021
2	PlatinumIBA 02/2020 - 01/2020
2	LipidsIBA 02/2020 - 01/2020
2	PhytochemicalsIBA 01/2020 - 02/2019
2	trioctyl phosphine oxide (TOPO)IBA 02/2019 - 06/2018
1	DNA AdductsIBA 02/2022
1	LigandsIBA 02/2022
1	fangchinoline (limacine)IBA 02/2022
1	Therapeutic UsesIBA 02/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	cisplatin-DNA adductIBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Ursolic AcidIBA 01/2022
1	Ethanol (Ethyl Alcohol)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Emodin (Archin)IBA 01/2022
1	SiliconesIBA 03/2021
1	EnzymesIBA 03/2021
1	Peptides (Polypeptides)IBA 03/2021
1	Estrogen ReceptorsIBA 03/2021
1	Pemetrexed (MTA)FDA Link 03/2021
1	hamamelitanninIBA 03/2021
1	AminopterinIBA 03/2021
1	Checkpoint Kinase 2IBA 01/2021
1	AbietanesIBA 01/2021
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2021
1	Checkpoint Kinase 1IBA 01/2021
1	Methadone (Dolophine)FDA LinkGeneric 01/2021
1	NucleotidesIBA 01/2021
1	Complementary DNA (cDNA)IBA 02/2020
1	Lipoprotein Receptors (Lipoprotein Receptor)IBA 02/2020
1	FlavonoidsIBA 01/2020
1	Anticarcinogenic AgentsIBA 01/2020
1	protoapigenoneIBA 01/2020
1	exemestane (Aromasin)FDA Link 11/2019
1	Biomarkers (Surrogate Marker)IBA 11/2019
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 02/2019
1	N-formyl-13-dihydrocarminomycin (NFD)IBA 02/2019
1	Monophenol Monooxygenase (Tyrosinase)IBA 10/2018
1	Melanins (Melanin)IBA 10/2018
1	heteroneminIBA 06/2018
1	SphingosineIBA 01/2018
1	Aldehyde DehydrogenaseIBA 11/2017
1	SmokeIBA 11/2017
1	Benzophenoneidum (Auramine O)IBA 11/2017
1	dehydropachymic acidIBA 11/2016
1	dehydroeburicoic acidIBA 11/2016
1	pachymic acidIBA 11/2016
1	AcidsIBA 11/2016
1	Matrix Metalloproteinases (MMPs)IBA 10/2016
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2016
1	Protein Kinase InhibitorsIBA 05/2015
1	halenaquinoneIBA 05/2015
1	quinone (benzoquinone)IBA 05/2015
1	Superoxides (Superoxide)IBA 08/2014
1	Pancreatic Elastase (Elastase)IBA 08/2014
1	DiterpenesIBA 08/2011
1	CaspasesIBA 08/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2011
1	gelomulide KIBA 08/2011

Therapy/Procedure

7	Therapeutics 02/2022 - 05/2015
4	Drug Therapy (Chemotherapy) 02/2020 - 01/2016
2	Adjuvant Chemotherapy 01/2020 - 01/2020
1	Chemoprevention 01/2020